Correlation Between International Business and Propanc Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both International Business and Propanc Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining International Business and Propanc Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between International Business Machines and Propanc Biopharma, you can compare the effects of market volatilities on International Business and Propanc Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in International Business with a short position of Propanc Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of International Business and Propanc Biopharma.

Diversification Opportunities for International Business and Propanc Biopharma

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between International and Propanc is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding International Business Machine and Propanc Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Propanc Biopharma and International Business is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on International Business Machines are associated (or correlated) with Propanc Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Propanc Biopharma has no effect on the direction of International Business i.e., International Business and Propanc Biopharma go up and down completely randomly.

Pair Corralation between International Business and Propanc Biopharma

Considering the 90-day investment horizon International Business is expected to generate 1.66 times less return on investment than Propanc Biopharma. But when comparing it to its historical volatility, International Business Machines is 13.36 times less risky than Propanc Biopharma. It trades about 0.12 of its potential returns per unit of risk. Propanc Biopharma is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  0.97  in Propanc Biopharma on August 24, 2024 and sell it today you would lose (0.94) from holding Propanc Biopharma or give up 96.91% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.6%
ValuesDaily Returns

International Business Machine  vs.  Propanc Biopharma

 Performance 
       Timeline  
International Business 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in International Business Machines are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal fundamental drivers, International Business displayed solid returns over the last few months and may actually be approaching a breakup point.
Propanc Biopharma 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Propanc Biopharma are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain fundamental indicators, Propanc Biopharma sustained solid returns over the last few months and may actually be approaching a breakup point.

International Business and Propanc Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with International Business and Propanc Biopharma

The main advantage of trading using opposite International Business and Propanc Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if International Business position performs unexpectedly, Propanc Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Propanc Biopharma will offset losses from the drop in Propanc Biopharma's long position.
The idea behind International Business Machines and Propanc Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios